---
title: "Softcare Switches Compliance Adviser to Ping An Following Personnel Change at Soochow"
description: "Softcare Limited has announced a change of compliance adviser, terminating its agreement with Soochow Securities effective January 12, 2026, due to personnel changes. Ping An of China Capital will tak"
type: "news"
locale: "en"
url: "https://longbridge.com/en/news/272262135.md"
published_at: "2026-01-12T11:40:31.000Z"
---

# Softcare Switches Compliance Adviser to Ping An Following Personnel Change at Soochow

> Softcare Limited has announced a change of compliance adviser, terminating its agreement with Soochow Securities effective January 12, 2026, due to personnel changes. Ping An of China Capital will take over as the new compliance adviser, ensuring oversight of post-listing compliance obligations. This appointment reflects Softcare's commitment to regulatory compliance. The latest analyst rating for Softcare's stock (HK:2698) is a Buy with a price target of HK$31.22.

### Claim 70% Off TipRanks Premium

-   Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
-   Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential

Softcare Limited ( (HK:2698) ) just unveiled an announcement.

Softcare Limited has announced a change of compliance adviser, mutually agreeing to terminate its existing agreement with Soochow Securities International Capital Limited effective 12 January 2026, following a change in Soochow’s key project personnel responsible for the company’s compliance work. To maintain continuity and senior-level oversight of its post-listing compliance obligations, Softcare has appointed Ping An of China Capital (Hong Kong) Company Limited as its new compliance adviser from the same date, with the mandate running at least until the company has reported its first full financial year’s results after listing or until the new advisory agreement is otherwise terminated; Ping An is licensed to provide corporate finance advisory services under Hong Kong’s securities regime, underscoring Softcare’s commitment to regulatory compliance and orderly interaction with the stock exchange and shareholders.

The most recent analyst rating on (HK:2698) stock is a Buy with a HK$31.22 price target. To see the full list of analyst forecasts on Softcare Limited stock, see the HK:2698 Stock Forecast page.

**More about Softcare Limited**

Softcare Limited is a Cayman Islands–incorporated company listed on the Main Board of the Hong Kong Stock Exchange under stock code 2698. It operates under Hong Kong listing and securities regulations and is overseen by a board comprising executive, non-executive and independent non-executive directors, reflecting a typical corporate governance structure for a newly listed issuer in the Hong Kong market.

**Average Trading Volume:** 1,998,388

### Related Stocks

- [02698.HK - SOFTCARE](https://longbridge.com/en/quote/02698.HK.md)

## Related News & Research

| Title | Description | URL |
|-------|-------------|-----|
| 瑞銀重申對樂舒適有限公司（2698）的買入評級 | 瑞銀分析師查爾斯·伊登（Charles Eden）重申了對樂舒適（Softcare Limited，2698）的買入評級，目標價為 41.00 港元，而該股收盤價為 33.28 港元。分析師對樂舒適的共識評級為強烈買入，目標價共識為 40. | [Link](https://longbridge.com/en/news/273589833.md) |
| 早盤趨勢｜樂舒適資金推高逼近壓力位，醫藥板塊短線機會浮現？ | 樂舒適（2698.HK）昨日表現強勢，資金推動股價逼近 143 元關鍵區間，盤中多次試探該區域壓力。醫藥醫療板塊 1 月初迎來局部升温，市場資金聚焦於行業定價權變化及合作協議落地帶來的業績彈性。近日，樂舒適所處細分賽道的龍頭企業發佈新合作協 | [Link](https://longbridge.com/en/news/271759879.md) |
| 神經治療公司在加拿大證券交易所以 NURL 代碼於東部時間上午 11:30 恢復交易 | 神經治療公司（Neural Therapeutics Inc.）已於東部時間上午 11:30 在加拿大證券交易所（CSE）恢復交易，交易代碼為 NURL。這是在加拿大投資監管組織（CIRO）實施的臨時交易暫停之後的恢復 | [Link](https://longbridge.com/en/news/276354716.md) |
| Euronext 奧斯陸證券交易所 - Parc Bidco AS - 已收到債券上市的申請 | Euronext Oslo Børs 已收到關於 ISIN NO0013478800 的申請，以便將其納入股票交易所上市。市場濫用法規（MAR）自申請提交之時起生效，包括髮行人的信息披露義務 | [Link](https://longbridge.com/en/news/276064747.md) |
| Euronext Oslo Børs - 關於 Pelagic Credit Plc.交易准入的決定 | Euronext Oslo Børs 已批准 Pelagic Credit Plc. 在 Euronext Growth Oslo 上進行交易。由於該公司自 2025 年 8 月 6 日起運營，並已準備好截至 2025 年 10 月 31  | [Link](https://longbridge.com/en/news/276064735.md) |

---

> **Disclaimer**: This article is for reference only and does not constitute any investment advice.